# Salvadora Persica-Zinc Oxide Versus MTA as Pulpotomy Agents in Mature Permanent Molars With Irreversible Pulpitis

> **NCT07630181** · NA · NOT_YET_RECRUITING · sponsor: **Postgraduate Medical Institute, Lahore** · enrollment: 78 (estimated)

## Conditions studied

- Irreversible Pulpitis

## Interventions

- **PROCEDURE:** Mineral Trioxide Aggregate
- **PROCEDURE:** Salvadora persica Extract + Zinc Oxide

## Key facts

- **NCT ID:** NCT07630181
- **Lead sponsor:** Postgraduate Medical Institute, Lahore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-20
- **Primary completion:** 2026-09-20
- **Final completion:** 2026-12-20
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2026-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07630181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07630181, "Salvadora Persica-Zinc Oxide Versus MTA as Pulpotomy Agents in Mature Permanent Molars With Irreversible Pulpitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07630181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*